LCD L38016: MolDX: Melanoma Risk Stratification Molecular Testing — CGS
Policy LCD-L38016 · Dermatology
New molecular testing for melanoma risk effective June 2025.
Code intelligence
C43.0 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C43.0.
Elevated code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Elevated
0
Critical
0%
3
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L39373: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma — Noridian
Policy LCD-L39373 · Dermatology
New billing codes for melanoma testing effective Jan 2026.
LCD L39375: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma — Noridian
Policy LCD-L39375 · Oncology
New LCD affects billing for melanoma molecular assays.
Audit documentation
Building an audit file that includes C43.0?
The Tripwire Audit Pack exports 12 months of Dermatology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Dermatology audit pack — $349One-time purchase · not a subscription